BCM
REPL icon

BlueCrest Capital Management’s Replimune Group REPL Stock Holding History

BlueCrest Capital Management’s Portfolio REPL Stock Details REPL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-14,621
Closed -$235K – 1323
2018
Q3 		$235K Buy
+14,621
New +$256K 0.01% 1187

Other funds holding REPL

OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
FCMI
Foresite Capital Management IV Larkspur, California $237M AUM 107.53% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
FCMI
Foresite Capital Management III Larkspur, California $37.9M AUM 6.87% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EA
Emerald Advisers Leola, Pennsylvania $3.16B AUM 109.58% 1-Year Est. Return
EMFAT
Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.06B AUM 106.87% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlueCrest Capital Management's REPL Position: Q4 2018 in Review

BlueCrest Capital Management sold out of Replimune Group (REPL) in Q4 2018, closing a stake of 14,621 shares — an estimated $235K sold.

BlueCrest Capital Management first reported a position in REPL in Q3 2018 and held it in 1 quarter. The position peaked at $235K in Q3 2018. 51 funds tracked by Wall St. Rank hold REPL as of Q4 2018.

  • BlueCrest Capital Management reported no remaining Replimune Group position as of Q4 2018 after selling out during the quarter.
  • BlueCrest Capital Management sold 14,621 Replimune Group shares in Q4 2018, an estimated $235K.
  • BlueCrest Capital Management first reported a position in Replimune Group in Q3 2018 and held it in 1 quarter.
  • BlueCrest Capital Management's Replimune Group position peaked at $235K in Q3 2018.
  • 51 funds tracked by Wall St. Rank held Replimune Group as of Q4 2018.

Based on BlueCrest Capital Management's 13F filing for Q4 2018, filed 14 Feb 2019.